User Reviews for Busulfex

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Busulfex.

Condition	Reviews	Compare	Avg. Ratings
Bone Marrow Transplantation	0 reviews	27 medications	Not rated - Be the first
Chronic Myelogenous Leukemia	0 reviews	18 medications	Not rated - Be the first
Thrombocythemia	0 reviews	4 medications	Not rated - Be the first

Reviews for Busulfex

There are no reviews - Be the first

Related Busulfex Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Positive evidence of risk

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Alkylating agents

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about Busulfex:

Related News and Articles

FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer 31 January 2012
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive...
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia 30 January 2012
Jan 27, 2012 - Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for standard review...
Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna(R) Compared to Gleevec(R) 13 December 2011
- ENESTcmr data show 23% of patients switched to Tasigna achieved undetectable levels of Bcr-Abl within 12 months compared to 11% who continued on...
Birth Defects Seem Rare in Kids of Childhood Cancer Survivors 12 December 2011
Children of parents who survived childhood cancer are unlikely to suffer from birth defects, finds a new study that should allay some concerns about long-term...
Cancer Patients Should Ask Doctors to Use Simple Terms 28 September 2011
Cancer patients are often faced with many difficult-to-understand treatment choices that can have serious side effects and even mean the difference between...

Help and Support

Looking for answers? Ask a question or go join the Busulfex support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Busulfex

Reviews for Busulfex

See also...

Related Busulfex Information